Streamlining Anthem (Elevance Health) TMS / Ketamine Prior Auth

Navigating the complexities of Anthem (Elevance Health) TMS / Ketamine prior auth is critical for timely patient access to care. Klivira provides a robust solution to automate and manage these specialized authorizations.

For revenue cycle directors and prior authorization coordinators, securing approvals for transcranial magnetic stimulation (TMS) and esketamine (Spravato) treatments from Anthem-licensed plans requires meticulous attention to payer-specific requirements. These high-cost, often time-sensitive therapies demand efficient workflows to minimize delays and reduce administrative burden.

Understanding Anthem's Prior Authorization Pathways for TMS and Ketamine

Anthem, operating under Elevance Health, manages prior authorizations for TMS and esketamine (Spravato) through distinct channels depending on the benefit type. TMS typically falls under the medical benefit, while esketamine (Spravato) is a pharmacy benefit drug, often requiring adherence to specific REMS programs and pharmacy PA processes.

Key Submission Channels for Medical and Pharmacy Benefits

For medical benefit services like TMS authorization, prior authorization submissions are primarily routed through Availity Essentials, Anthem's multi-payer provider workspace. Practices can also submit X12 278 transactions via clearinghouses.
For pharmacy benefit drugs such as esketamine (Spravato), authorizations are processed by CarelonRx (Elevance Health's PBM). Prescriber-initiated workflows often leverage ePA partners like CoverMyMeds and Surescripts for retail PA.
Behavioral health services for many Anthem lines are managed through Carelon Behavioral Health; verify specific carve-out arrangements per line of business and state for TMS and esketamine.

Clinical Documentation and Policy Adherence for Behavioral Health Services

Securing approval for TMS and esketamine requires comprehensive clinical documentation demonstrating medical necessity, often including prior treatment documentation. Anthem operating companies publish medical policies and clinical utilization management guidelines through provider sites accessible via Availity, with state-specific Medicaid and Medicare Advantage variants. Ensure citations reference the specific policy number, plan-state context, and effective date.

Navigating Turnaround Times and Electronic PA Capabilities with Anthem (Elevance Health)

Prior authorization turnaround times for Anthem-licensed plans are governed by state insurance regulations for commercial lines, with material variance across states. For Medicare Advantage, Medicaid managed-care, and QHP-on-FFM lines, Anthem is an impacted payer under CMS-0057-F, subject to phased compliance for 72-hour standard and 24-hour expedited decision timeframes. Elevance Health has participated in Da Vinci Project initiatives and HL7 connectathons, indicating a strategic direction toward electronic prior authorization (ePA), though specific conformance status requires verification of current public disclosures. Retail pharmacy ePA is supported via CoverMyMeds and Surescripts through CarelonRx.

Common Denial Reasons and Appeal Pathways

Denials for TMS and esketamine often stem from insufficient documentation to prove medical necessity, lack of demonstrated prior treatment documentation, or failure to complete step therapy requirements.
Site-of-service mismatch can also be a factor given Anthem's active site-of-care policies, even for behavioral health services.
Anthem returns denials via X12 277/835 transactions and Availity status updates. Appeals for standard medical PA follow the process documented in the Anthem provider manual, with peer-to-peer reviews available.

Automating Anthem (Elevance Health) TMS / Ketamine Prior Auth with Klivira

Klivira integrates directly with your EMR and Anthem's diverse submission channels, including Availity, X12 278, and ePA partners like CoverMyMeds and Surescripts. Our platform automates documentation assembly, submission tracking, and status updates, significantly reducing manual effort and accelerating approval cycles for TMS and esketamine treatments. This enables your team to focus on patient care rather than administrative tasks.

Frequently asked questions

How do I submit a prior authorization for TMS to Anthem (Elevance Health)?

For Transcranial Magnetic Stimulation (TMS), which is typically a medical benefit, prior authorizations are primarily submitted through Availity Essentials, Anthem's multi-payer provider portal. You can also utilize X12 278 transactions via your clearinghouse. Ensure all required clinical documentation, including prior treatment history, is attached.

What is the process for esketamine (Spravato) prior authorization with Anthem?

Esketamine (Spravato) is a pharmacy benefit drug. Prior authorizations are handled by CarelonRx, Elevance Health's in-house PBM. Prescribers can often initiate these PAs electronically through ePA platforms like CoverMyMeds or Surescripts, or via the CarelonRx provider portal. Adherence to Spravato REMS program requirements is crucial.

Where can I find Anthem's medical policies for TMS or esketamine?

Anthem operating companies publish their medical policies and clinical utilization management guidelines on provider websites, typically accessible through Availity. It's essential to consult the specific policy number, plan-state context, and effective date, as criteria can vary by state and line of business.

What are the typical turnaround times for Anthem prior authorizations?

Turnaround times vary. For commercial plans, state insurance regulations dictate minimums. For Medicare Advantage and Medicaid managed-care plans, Anthem is subject to CMS-0057-F, which mandates 72-hour standard and 24-hour expedited decision timeframes on a phased compliance timeline. Always verify the current payer-published service-level targets.

What are common reasons for denial for TMS or Ketamine PAs from Anthem?

Common denial reasons include insufficient documentation to prove medical necessity, failure to meet step therapy requirements, or a mismatch in the proposed site-of-service. It's vital to provide comprehensive clinical records, including evidence of prior failed treatments, to support the authorization request.